Related Experiment Video
Updated: Jul 20, 2026
05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Metabolic consequences of bariatric surgery
Raymond J Lynch1, Dan Eisenberg, Robert L Bell
1Department of Surgery, Section of Gastrointestinal Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
Journal of Clinical Gastroenterology
|August 31, 2006
Summary
Surgical obesity treatment effectively reduces weight and improves health, but requires careful management of gastrointestinal and metabolic changes to prevent severe complications. Patient and surgeon precautions are vital for successful outcomes.
Area of Science:
- Bariatric surgery
- Metabolic surgery
- Obesity treatment
Background:
- Obesity is a leading cause of preventable illness and death.
- Surgical therapy offers significant weight reduction and comorbidity amelioration.
- Bariatric procedures involve substantial gastrointestinal manipulation.
Purpose of the Study:
- To present the metabolic consequences of various bariatric procedures.
- To highlight necessary postoperative precautions.
- To discuss considerations for specific patient populations.
Main Methods:
- Review of metabolic consequences of jejunoileal bypass.
- Analysis of modern bariatric procedures (Roux-Y gastric bypass, gastroplasty, biliopancreatic diversion).
- Identification of nutritional and metabolic changes requiring compensation.
Main Results:
- Bariatric surgery is highly effective for weight loss and comorbidity management.
- Metabolic consequences can be severe without proper precautions.
- Nutritional and metabolic changes must be anticipated and managed.
- Modern procedures are safer but still require careful monitoring.
Conclusions:
- Bariatric surgery is a powerful tool for obesity management.
- Proactive management of metabolic and nutritional changes is crucial for patient safety and surgical success.
- Understanding procedure-specific consequences and patient factors optimizes outcomes.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:18Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...